Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 1, 1995
A prognostic value of CA 19-9 but not of CEA in patients with gastric cancerM Victorzon, C Haglund, J Lundin, et al.
Anticancer Research|September 1, 1995
Prognostic significance of serum CA 242 in pancreatic cancer. A comparison with CA 19-9J Lundin, P J Roberts, P Kuusela, et al.
Scandinavian Journal of Gastroenterology|January 1, 1992
Tumour markers CA 19-9 and CA 50 in digestive tract malignanciesC Haglund, P J Roberts, H Jalanko, et al.
Cancer Research|September 1, 1992
Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary diseaseH Alfthan, C Haglund, P Roberts, et al.
International Journal of Cancer|May 3, 1996
Serum trypsinogen-2 and trypsin-2-alpha(1)-antitrypsin complex in malignant and benign digestive-tract diseases. Preferential elevation in patients with cholangiocarcinomasJ Hedström, C Haglund, R Haapiainen, et al.
Annales Chirurgiae Et Gynaecologiae|January 1, 1989
Tumour markers in gastric cancerP J Roberts, C Haglund, M Onali, et al.
British Journal of Cancer|February 1, 1986
Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitisC Haglund, J Lindgren, P J Roberts, et al.
Clinical Chemistry|October 1, 1992
Concentrations of human choriogonadotropin, its beta-subunit, and the core fragment of the beta-subunit in serum and urine of men and nonpregnant womenH Alfthan, C Haglund, J Dabek, et al.
Thrombosis Research|March 14, 2000
Alteration of the fibrinogen molecule and its phosphorylation state in myocardial infarction patients undergoing thrombolytic treatmentA C Haglund, G Ronquist, G Frithz, et al.
British Journal of Cancer|March 1, 1994
The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancerJ Lundin, P J Roberts, P Kuusela, et al.
Pageof 11